Product Program year 2019 Source: CMS Open Payments

Zevalin

Drug Oncology

NDC 68152-103-03

Open in the dashboard

General payments

$1,503

41 payments

Research payments

$0

0 payments

Through program year 2019, $1,503 in general payments and $0 in research payments were reported against Zevalin (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $1,503 41

Breakdown

Who paid General payments · program year 2019
  1. Spectrum Pharmaceuticals Inc. $1,503 41 payments
Top recipients General payments · program year 2019
  1. Pradip Rustagi Hematology & Oncology · Bend, OR $100 7% · 1 payment
  2. Shawn Shambaugh Bakersfield, CA $100 7% · 1 payment
  3. David Kanamori Bakersfield, CA $100 7% · 1 payment
  4. Neal Ammar Dermatology · Redondo Beach, CA $100 7% · 1 payment
  5. Ajay Desai Radiation Oncology · Bakersfield, CA $100 7% · 1 payment

The top 5 of 41 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $689 60% · 20 practitioners
  2. Medical Oncology Internal Medicine $175 15% · 9 practitioners
  3. Radiation Oncology Radiology $170 15% · 5 practitioners
  4. Dermatology $100 9% · 1 practitioner
  5. Internal Medicine $19 2% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. California $917 61% · 10 recipients
  2. Arizona $261 17% · 14 recipients
  3. Tennessee $78 5% · 5 recipients
  4. New York $61 4% · 2 recipients
  5. Florida $37 2% · 2 recipients

The top 5 of 12 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

41 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record